Valuation (12%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 0.00 | 44.33 |
| PEG Ratio (TTM) | N/A | 8.68 |
| P/S Ratio (TTM) | 7.15 | 15.92 |
| P/B Ratio (TTM) | 5.34 | 16.16 |
| P/FCF Ratio (TTM) | -14.59 | 48.34 |
| Price to 5YR AVG Earnings Ratio | N/A | 20.48 |
| Price to 5YR AVG FCF Ratio | N/A | 56.68 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -6,687,629.51% | 12.52% |
| ROE (TTM) | -7,754,621.51% | 57.43% |
| Net Profit Margin (TTM) | -12,462,978.12% | 24.07% |
| ROIC 5YR AVG | N/A | -10.50% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -5,816,259.45% | -172.53% | N/A |
| Revenue | -2.39% | 91.27% | N/A |
| Net Income | -6,348,029.88% | -216.46% | N/A |
| Cash Flow | 24.80% | -117.89% | N/A |
Health (11%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.83 | 1.54 |
| Quick Ratio (TTM) | 0.83 | 1.53 |
| D/E Ratio (TTM) | N/A | 0.90 |
| Interest Coverage (TTM) | N/A | 55.39 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | N/A | 11.47 |
| LTL to 5YR AVG FCF | N/A | 4.85 |
| Shares Outstanding Growth 5YR AVG | N/A | 1.78% |